Abstract
This exploratory study attempted to uncover behavioral and physical outcomes of changes in the peripheral SMS system in the first postnatal week. On postnatal days 1–7, Sprague-Dawley rat pups received daily s.c. injections of Somatostatin (SMS; 8 or 40 μg/kg), saline, or CPP-1 (8 or 40 μg/kg), a putative SMS receptor antagonist. Physical growth and neurobehavioral development of the pups, assessed on days 3, 6, 9 and 12, were not affected, in 3 separate replications (n = 11/treatment/ replication). In contrast, neonatal CPP-1 (40 μg/kg) reduced separation distress on day 14, as measured by ultrasonic vocalization and activity. In addition, neonatal SMS (40 μg/kg) tended to impair learning on a milk-rewarded Y-maze on days 15–16. These findings support further examination of the potential role of SMS in behavioral development.